Grifols
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Grifols and buy or sell other stocks, ETFs, and their options commission-free!About GRFS
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others.
CEOJose Ignacio Abia Buenache
CEOJose Ignacio Abia Buenache
Employees23,833
Employees23,833
HeadquartersBarcelona, Catalonia
HeadquartersBarcelona, Catalonia
Founded1909
Founded1909
Employees23,833
Employees23,833
GRFS Key Statistics
Market cap7.52B
Market cap7.52B
Price-Earnings ratio14.30
Price-Earnings ratio14.30
Dividend yield1.62%
Dividend yield1.62%
Average volume642.22K
Average volume642.22K
High today$9.01
High today$9.01
Low today$8.75
Low today$8.75
Open price$8.82
Open price$8.82
Volume248.51K
Volume248.51K
52 Week high$11.14
52 Week high$11.14
52 Week low$6.19
52 Week low$6.19
Stock Snapshot
The current Grifols(GRFS) stock price is $8.89, with a market capitalization of 7.52B. The stock trades at a price-to-earnings (P/E) ratio of 14.30 and offers a dividend yield of 1.6%.
During the trading session on 2025-12-04, Grifols(GRFS) shares reached a daily high of $9.01 and a low of $8.75. At a current price of $8.89, the stock is +1.6% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 248.51K, compared to an average daily volume of 642.22K.
The stock's 52-week range extends from a low of $6.19 to a high of $11.14.
The stock's 52-week range extends from a low of $6.19 to a high of $11.14.